Skip to Main Content

Metformin Outcomes in Cancer

Use of Metformin and Outcomes in Older Patients with Classical Myeloproliferative Neoplasms

The purpose of this study is to evaluate hematologic and cardiovascular outcomes in older adult patients with myeloproliferative neoplasms who received metformin by leveraging a large prospective cohort of patients derived from the Surveillance, Epidemiology and End-Results Medicare-linked database.

Funding Source: American Society of Hematology

Principal Investigator: Jessica M. Stempel